-
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.
Nat Immunol. 2004 May;5(5):503-7
PMID: 15064760
-
A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins.
PLoS One. 2007 Aug 29;2(8):e788
PMID: 17726518
-
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
J Exp Med. 2003 Oct 6;198(7):1043-55
PMID: 14517278
-
NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3372-7
PMID: 17360653
-
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Nature. 2001 Sep 6;413(6851):78-83
PMID: 11544529
-
Targeting toll-like receptor signaling pathways for design of novel immune therapeutics.
Curr Drug Discov Technol. 2008 Mar;5(1):29-38
PMID: 18537565
-
A structural bioinformatics approach to the analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) and their relation to disease.
J Bioinform Comput Biol. 2007 Dec;5(6):1297-318
PMID: 18172930
-
When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction.
Immunity. 2008 Jul 18;29(1):12-20
PMID: 18631453
-
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Nat Immunol. 2003 May;4(5):491-6
PMID: 12692549
-
Prediction of the stability of protein mutants based on structural environment-dependent amino acid substitution and propensity tables.
Protein Eng. 1997 Jan;10(1):7-21
PMID: 9051729
-
Comparative protein modelling by satisfaction of spatial restraints.
J Mol Biol. 1993 Dec 5;234(3):779-815
PMID: 8254673
-
FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties.
J Mol Biol. 2001 Jun 29;310(1):243-57
PMID: 11419950
-
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.
J Biol Chem. 2005 Apr 29;280(17):17005-12
PMID: 15695821
-
Pyogenic bacterial infections in humans with MyD88 deficiency.
Science. 2008 Aug 1;321(5889):691-6
PMID: 18669862
-
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
Nature. 2000 Nov 2;408(6808):111-5
PMID: 11081518
-
TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA.
Cell Host Microbe. 2008 Dec 11;4(6):543-54
PMID: 19064255
-
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.
Nat Immunol. 2008 Aug;9(8):857-65
PMID: 18604209
-
The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
Mol Immunol. 2004 Jul;41(6-7):577-82
PMID: 15219996
-
Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis.
PLoS Genet. 2008 Oct;4(10):e1000218
PMID: 18927625
-
Sequence variability and protein domain architectures for bovine Toll-like receptors 1, 5, and 10.
Genomics. 2007 Oct;90(4):502-15
PMID: 17719743
-
TIRAP: an adapter molecule in the Toll signaling pathway.
Nat Immunol. 2001 Sep;2(9):835-41
PMID: 11526399
-
Versatile retroviral vectors for potential use in gene therapy.
Gene Ther. 1994 Mar;1(2):136-8
PMID: 7584069
-
TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Nat Immunol. 2004 Feb;5(2):190-8
PMID: 14716310
-
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
Nat Genet. 2007 Apr;39(4):523-8
PMID: 17322885
-
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Nature. 2002 Nov 21;420(6913):324-9
PMID: 12447441
-
Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling.
Cell. 2006 Jun 2;125(5):943-55
PMID: 16751103
-
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.
J Immunol. 2007 Jun 15;178(12):7520-4
PMID: 17548585
-
Sorting out Toll signals.
Cell. 2006 Jun 2;125(5):834-6
PMID: 16751092
-
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16645-50
PMID: 17925445
-
Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
J Immunol. 2008 May 1;180(9):6107-15
PMID: 18424732
-
A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis.
J Infect Dis. 2006 Oct 15;194(8):1127-1134
PMID: 16991088
-
Pyogenic bacterial infections in humans with IRAK-4 deficiency.
Science. 2003 Mar 28;299(5615):2076-9
PMID: 12637671
-
TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.
Mol Interv. 2003 Dec;3(8):466-77
PMID: 14993454
-
Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response.
J Biol Chem. 2008 May 23;283(21):14295-308
PMID: 18332133
-
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections.
J Exp Med. 2003 Aug 18;198(4):521-31
PMID: 12925671
-
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.
Am J Respir Crit Care Med. 2008 Oct 1;178(7):710-20
PMID: 18635889
-
Genomic variants of TLR1--it takes (TLR-)two to tango.
Eur J Immunol. 2007 Aug;37(8):2059-62
PMID: 17654751